Biocryst Pharmaceuticals reported $-44584000 in EBIT for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -181677000 35.52M
Biocryst Pharmaceuticals BCRX:US $ -44584000 15M
Chemocentryx CCXI:US $ -21803000 16.93M
Chugai Pharma 4519:JP 122.16B 25.44B
Daiichi Sankyo 4568:JP 38.97B 6.8B
Gilead Sciences GILD:US $ 3883M 1637M
GlaxoSmithKline GSK:LN 2.67B 712M
Glaxosmithkline GSK:US 2.67B 712M
Intra Cellular Therapies ITCI:US $ -77323830 8.18M
IONIS PHARMACEUT IONS:US $ -85849000 12.88M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Mirati Therapeutics MRTX:US $ -79499000 84.69M
Neurocrine Biosciences NBIX:US $ 44.5M 23.3M
Novavax NVAX:US $ -307144000 38.68M
Ptc Therapeutics PTCT:US $ -93076000 5.42M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Sarepta Therapeutics SRPT:US $ -34458000 133.12M
Ultragenyx Pharmaceutical RARE:US $ -89828000 7.05M
Vertex Pharmaceuticals VRTX:US $ 1055.71M 1092.07M
YTE INCY:US $ 247.47M 92.16M
Zogenix ZGNX:US $ -53870000 1.56M